• Facebook
  • Twitter
  • Youtube
  • LinkedIn
HOME | CONTACT US: 185 Devonshire Street, Suite 1101 Boston, MA 02110 | 617-723-2277 | pioneer@pioneerinstitute.org
Pioneer Institute
  • ABOUT
    • About Pioneer
    • Pioneer’s Mission
    • Pioneer’s Staff
    • Board of Directors
    • Academic Advisors
    • Annual Reports
    • Pioneer’s Financial Information
    • Pioneer’s Employment Opportunities
      • Outreach Manager
      • Attorney – PioneerLegal
      • Economic Opportunity Director
      • Grant Writer (P-T or Contract)
      • Roger Perry Internship Program
      • Pioneer’s Internship Program
  • RESEARCH
    • Policy Research
    • Policy Overview
    • PioneerEducation
      • BOOK: Hands-On Achievement
      • BOOK: A Vision of Hope – Catholic Schooling in Massachusetts
      • Remote Learning Resources during COVID
      • Podcast: “The Learning Curve”
      • End the Blaine Amendments
      • Civil Rights and Education Reform
      • School Choice
      • US History Instruction
      • Higher Education
      • Common Core National Education Standards
      • Academic Standards
    • PioneerHealth
      • Healthcare Price Transparency
      • Protect Patients, Promoting Cutting-Edge Innovations
      • Affordable, Innovative Care
      • Hewitt Healthcare Lecture
      • Book: U-Turn: America’s Return to State Healthcare Solutions
    • PioneerLegal
    • PioneerOpportunity
      • New Book: “Back to Taxachusetts?”
      • Business Recovery & Taxes
      • City Spotlights
    • PioneerTransportation
    • PioneerPublic
      • Government Transparency
      • Criminal Justice
      • Better Government Competition
      • Benchmarking City Performance
      • Unfunded Liabilities
    • COVID Resources
  • MASS WATCH
    • MASSWATCH
    • COVID-19 Age-Group Tracker
    • COVID-19 Vaccine Tracker
    • COVID Tracker for Long-Term Care Facilities
    • MAPPING COVID-19
    • COVID UNEMPLOYMENT TRACKER
    • MASS IRS DATA DISCOVERY
    • MASS REPORT CARDS
    • MASS ECONOMIX
    • MASS OPEN BOOKS
    • FINANCIAL DISCLOSURE
    • MBTA ANALYSIS
    • MASS PENSIONS
    • MUNI SHARE
    • MASS ANALYSIS
  • MULTIMEDIA
    • Podcasts
      • The Learning Curve Podcast
      • JobMakers Podcast
      • Hubwonk Podcast
    • Blog
    • Videos
    • Op-eds
    • Pioneer in the Press
  • EVENTS
    • Our Events
  • DONATE
    • Donate
    • Membership
    • Pioneer Young Professionals (PYP) Network
    • Ways to Donate
    • Tyler Family Memorial Fund
  • MORE…
    • Subscribe to our Newsletter
    • Policy Research
    • Press Releases
    • Podcasts
      • Jobmakers
      • Hubwonk Podcast
      • The Learning Curve Podcast
    • Videos
    • Blog
    • Op-Eds
    • Pioneer in the Press
    • Bookstore
  • Search
  • Menu Menu
Donate

Protect Patients, Promoting Cutting-Edge Innovations

As states continue to consider proposals to curb spending on prescription drugs, “cost-effectiveness” reviews such as those conducted by the Institute for Clinical and Economic Review (ICER) are being considered as one method to determine treatment access and reimbursement. Pioneer Institute explores the potential impacts that ICER and other “one-size-fits-all” methods to healthcare value assessment could have for certain patient populations and medical innovation.

Get Updates on our Work to Protect Patients and Innovation!

Get Updates on our Work to Protect Patients and Innovation!

Read Pioneer Institute Research:

Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes

March 22, 2022/by Editorial Staff

The Promise and Challenges of Rare Cancer Treatments

December 6, 2021/by Editorial Staff

Study: Decline in Cardiovascular Health Screenings During COVID-19 Pandemic Poses New Public Health Threat

November 9, 2021/by Editorial Staff

New Analysis: ICER Framework Ignores Patient Preferences, Innovation & Societal Benefits in Evaluating Cost-Effectiveness of New Cancer Treatments

April 6, 2021/by Editorial Staff

Recent Media Coverage:

A Modest Proposal to Raise Federal Revenue

September 27, 2021/by William Smith

ICER Proves Its Lack of Business Acumen, Again

February 3, 2021/by William Smith

Report: Rare Disease Patients Hurt by “One-Size-Fits-All” ICER Framework

June 26, 2019/by Editorial Staff

Putting a Price on Life: The Coming Fight Over Government Rationing of Medical Care

June 12, 2019/by Editorial Staff

Here’s why Sarah Palin’s ‘death panels’ are now being debated in Massachusetts

April 25, 2019/by Editorial Staff

Issue Brief: Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology

April 23, 2019/by Editorial Staff

Commentary: Proposed Drug Price Caps Would Stall Advances in Health Care

April 23, 2019/by Editorial Staff

HHS Secretary Alex Azar doesn’t want drug access to become an equation

April 18, 2019/by Editorial Staff

More Media Coverage:

March 17, 2020

New York Post: Don’t let bureaucrats block insurance for our cystic-fibrosis kids

March 3, 2020

The Washington Times: Americans stand to lose a lot with Medicare for All, especially children

November 14, 2019

STAT News: Working with ICER, or around it, on cost-effectiveness estimates

October 16, 2019

NJ Spotlight: A Troubling Method of Curbing Health Care Costs Is Gaining Ground

October 3, 2019

San Francisco Examiner: ICER discriminates against people with rare diseases

TAKE ACTION TO PROTECT PATIENTS AND INNOVATION:

Click here to download our digital advocacy toolkit of social media, email, and website content resources to share information on how ICER threatens patients and innovation.

Read Research From Other Experts:

November 6, 2019

National Council on Disability (NCD): Quality-Adjusted Life Years and the Devaluation of Life with Disability

April 23, 2019

MacIver Institute: Issue Brief – Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology

March 20, 2019

Xcenda: Applying ICER Assessments in Medicaid Could Limit Patients’ Access to Medicines

Make a tax-deductible gift below to support our work to protect patients.

Scroll to top